There is an urgent need to understand the behavior of the novel coronavirus
(SARS-COV-2), which is the causative agent of COVID-19, and to develop point-of-care
diagnostics. Here, a glyconanoparticle platform is used to discover that
N
-acetyl neuraminic acid has affinity toward the SARS-COV-2 spike
glycoprotein, demonstrating its glycan-binding function. Optimization of the particle
size and coating enabled detection of the spike glycoprotein in lateral flow and showed
selectivity over the SARS-COV-1 spike protein. Using a virus-like particle and a
pseudotyped lentivirus model, paper-based lateral flow detection was demonstrated in
under 30 min, showing the potential of this system as a low-cost detection platform.